Indication

Prevention of ventricular fibrillation

Prevention of ventricular fibrillation refers to clinical strategies aimed at averting a catastrophic, life-threatening cardiac arrhythmia characterized by rapid, disorganized electrical impulses within the ventricles. Read more about Prevention of ventricular fibrillation

39 drugs 38 manufacturers

Advertisement

Drugs that treat it

Common Prevention of ventricular fibrillation therapies.

Showing 28–36 of 39 drugs

AMIODARONE HCL

ANTIARRHYTHMIC - CLASS III·LIFE-THREATENING VENTRICULAR TACHYCARDIA·+2
BRYANT RANCH PR

AMIODARONE HCL

ANTIARRHYTHMIC - CLASS III·LIFE-THREATENING VENTRICULAR TACHYCARDIA·+2
SKY PHARMACEUTI

AMIODARONE HCL

ANTIARRHYTHMIC - CLASS III·LIFE-THREATENING VENTRICULAR TACHYCARDIA·+2
SLATE RUN PHARM

AMIODARONE HCL

ANTIARRHYTHMIC - CLASS III·LIFE-THREATENING VENTRICULAR TACHYCARDIA·+2
ADVAGEN PHARMA

AMIODARONE HCL

ANTIARRHYTHMIC - CLASS III·LIFE-THREATENING VENTRICULAR TACHYCARDIA·+2
AHP

AMIODARONE HCL

ANTIARRHYTHMIC - CLASS III·LIFE-THREATENING VENTRICULAR TACHYCARDIA·+2
MYLAN INST-NOVA

AMIODARONE HCL

ANTIARRHYTHMIC - CLASS III·LIFE-THREATENING VENTRICULAR TACHYCARDIA·+2
Hikma Pharmaceuticals USA

AMIODARONE HCL

ANTIARRHYTHMIC - CLASS III·LIFE-THREATENING VENTRICULAR TACHYCARDIA·+2
FRESENIUS KABI
Filter & compare in the drug finder →Opens the drug finder with Prevention of ventricular fibrillation preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Prevention of ventricular fibrillation.

Prevention of ventricular fibrillation refers to clinical strategies aimed at averting a catastrophic, life-threatening cardiac arrhythmia characterized by rapid, disorganized electrical impulses within the ventricles.

This electrical chaos disrupts coordinated mechanical contraction, causing the lower chambers to fibrillate rather than pump blood, which leads to immediate loss of cardiac output, abrupt hemodynamic collapse, and sudden cardiac death if not promptly terminated.

It primarily affects the cardiovascular system, particularly in individuals with ischemic heart disease, acute myocardial infarction, structural cardiomyopathies, or congenital channelopathies.

Prophylaxis encompasses both primary prevention in vulnerable populations with electrophysiological instability and secondary prevention against recurrence in survivors of previous sustained ventricular tachyarrhythmias.

Personalize your experience

Follow Prevention of ventricular fibrillation and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it